The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial - Scorecard - MDSpire

The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial

  • By

  • Qinggang Ge

  • Libo Zheng

  • Man Zhao

  • Chao Li

  • Zhiling Zhao

  • Zongyu Wang

  • Qiang Zhang

  • Mai Shi

  • Yuxuan Li

  • Jianan Zhang

  • Yixian Qiao

  • Senhao Wei

  • Ning Shen

  • Haomiao Long

  • Yongjun Liu

  • Jie Qiao

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Safety and Preliminary Efficacy of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells in Patients with Acute Respiratory Distress Syndrome: Results from a Multicenter Phase 1 Open-Label Trial

At a Glance

CategoryDetail
Condition
Key MechanismsRemove or rephrase to ensure it is directly supported by the source.
Target Population
Care Setting

Key Highlights

  • 0

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • '
    • p
    • l
    • u
    • s
    • a
    • s
    • i
    • n
    • g
    • l
    • e
    • i
    • n
    • t
    • r
    • a
    • v
    • e
    • n
    • o
    • u
    • s
    • i
    • n
    • f
    • u
    • s
    • i
    • o
    • n
    • o
    • f
    • B
    • C
    • -
    • U
    • 0
    • 0
    • 1
    • '
    • u
    • n
    • l
    • e
    • s
    • s
    • d
    • i
    • r
    • e
    • c
    • t
    • l
    • y
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        12 eligible patients with mild-to-moderate ARDS.

        Middle dose of hUC-MSCs showed promising therapeutic effects.

        Clinical Best Practices

        • 0

        Related Resources & Content

          Original Source(s)

          The safety and efficacy of human umbilical cord mesenchymal stem cell for acute respiratory distress syndrome: an open-label and multicenter phase 1 clinical trial

          • by Qinggang Ge, Libo Zheng, Man Zhao, Chao Li, Zhiling Zhao, Zongyu Wang, Qiang Zhang, Mai Shi, Yuxuan Li, Jianan Zhang, Yixian Qiao, Senhao Wei, Ning Shen, Haomiao Long, Yongjun Liu, Jie Qiao

          • June 10, 2026

          Related Content

          Nomograms to predict severe PH and survival in COPD patients using non-invasive parameters

          Specialty Areas in Respiratory Care that Offer a Slower Pace

          The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis